(a) Clinical characteristics of 11 TNBC tumors
LTQ Orbitrap sample ID | Patient age | Ethnicity | TR % | Response | T stage | Histological type | ER | PR | FISH R/G ratio | Neoadjuvant |
---|---|---|---|---|---|---|---|---|---|---|
#1 | 61 | White | 80 | R | T3 | IDC | − | − | 1.10 | TC |
#2 | 29 | Hispanic | −60 | NR | T3 | IDC | − | − | 0.92 | TC |
#5 | 55 | Hispanic | 100 | R (pCR) | T3 | IDC | − | − | 0.92 | TC |
#6 | 54 | Hispanic | 100 | R (pCR) | T3 | IDC | − | − | 1.01 | TC |
#7 | 40 | Asian | 45 | IR | T3 | IDC | − | − | 1.17 | TC |
#8 | 44 | White | 100a | R (pCR) | T3 | IDC | − | − | 1.00 | TC |
#9 | 49 | Hispanic | 48 | IR | T4 | IDC | − | − | 1.10 | TC |
#10 | 53 | White | 100 | R (pCR) | T3 | IDC | − | − | 1.20 | TC |
#11 | 84 | Asian | 100 | R (pCR) | T4 | IDC | − | − | 1.03 | TC |
#36 | 45 | Hispanic | 30 | IR | T3 | IDC | − | − | 1.27 | TC |
#37 | 38 | White | 100 | R (pCR) | T2 | IDC | − | − | 1.10 | TC |
aLN positive without residual primary cancer.